XML 55 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Stock-Based Compensation (Tables)
 12 Months Ended
Jan. 29, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of stock-based compensation The following table provides total stock-based compensation recognized in the Consolidated Statements of Income for the fiscal years presented (in thousands):
202120202019
Stock option expense
$5,338 $6,186 $6,286 
Restricted stock expense
47,462 43,991 37,207 
Total stock-based compensation expense$52,800 $50,177 $43,493 
Total related tax benefit
$9,927 $10,443 $9,620 
Schedule of assumptions used to estimate the fair value of stock-based awards to employees The following weighted-average assumptions were used in the Black-Scholes option valuation model for awards granted in the fiscal years presented:
 
Employee Stock Option Plans

202120202019
Exercise price$72.40$17.80$38.58
Expected term (years) 
4.805.565.39
Expected volatility47.97 %41.31 %35.75 %
Risk-free interest rate 
0.73%
0.78%
2.05%
Expected dividend yield
2.00%
6.27%
2.77%
Grant date fair value$25.20$3.70$10.59
Schedule of stock option activity Fiscal 2021 stock option activity is presented in the following table:
Shares Subject to OptionsWeighted Average Exercise Price per ShareWeighted Average Remaining Contractual Life (Years)Aggregate Intrinsic Value (in millions)
Outstanding, January 30, 20214,352,896 $29.28 4.96$164.2 
Granted1,488 72.40 
Exercised(657,234)40.09 
Forfeited / Expired(22,378)19.53 
Outstanding, January 29, 20223,674,772 $21.78 4.21$335.9 
Exercisable, January 29, 20221,480,866 $30.46 3.18$122.5 
Vested or expected to vest, January 29, 20223,514,737 $22.03 4.17$320.4 
The following table presents stock option information for the last three fiscal years (in millions):
202120202019
Total intrinsic value of stock options exercised$37.1 $8.3 $1.0 
Income tax benefit (expense) from the exercise of stock options$6.8 $(0.6)$(0.2)
Total fair value of stock options vested$6.3 $6.1 $7.0 
Schedule of nonvested restricted stock activity
Restricted stock activity, including performance-based restricted stock, for fiscal 2021 is presented in the following table:
SharesWeighted Average Grant Date Fair ValueIntrinsic Value (in millions)
Nonvested, January 30, 20214,893,732 $26.54 $327.9 
Granted716,402 92.74 
Released from restrictions(1,151,177)33.63 
Forfeited(224,550)26.96 
Nonvested, January 29, 20224,234,407 $35.79 $479.3